Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)

CNY 11.7

(2.9%)

Gross Profit Summary of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd's latest annual gross profit in 2023 was 659.13 Million CNY , down -8.79% from previous year.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd's latest quarterly gross profit in 2024 Q3 was 416.57 Million CNY , down -8.12% from previous quarter.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported a annual gross profit of 1.94 Billion CNY in annual gross profit 2022, down -6.98% from previous year.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported a annual gross profit of 2.09 Billion CNY in annual gross profit 2021, up 21.64% from previous year.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported a quarterly gross profit of 416.57 Million CNY for 2024 Q3, down -8.12% from previous quarter.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported a quarterly gross profit of 382.65 Million CNY for 2024 Q1, up 25.92% from previous quarter.

Annual Gross Profit Chart of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (2023 - 2013)

Historical Annual Gross Profit of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (2023 - 2013)

Year Gross Profit Gross Profit Growth
2023 659.13 Million CNY -8.79%
2022 1.94 Billion CNY -6.98%
2021 2.09 Billion CNY 21.64%
2020 1.71 Billion CNY 35.82%
2019 1.26 Billion CNY 50.44%
2018 841.09 Million CNY 62.99%
2017 516.04 Million CNY 110.71%
2016 244.9 Million CNY 90.38%
2015 128.64 Million CNY 43.11%
2014 89.89 Million CNY -31.86%
2013 131.92 Million CNY 0.0%

Peer Gross Profit Comparison of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

Name Gross Profit Gross Profit Difference
Dali Pharmaceuticalco.,Ltd 36.29 Million CNY -1715.964%
China Animal Husbandry Industry Co., Ltd. 1.06 Billion CNY 38.314%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.9 Billion CNY 65.363%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.74 Billion CNY 62.291%
Tasly Pharmaceutical Group Co., Ltd 5.66 Billion CNY 88.355%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 3.61 Billion CNY 81.754%
North China Pharmaceutical Company Ltd. 3.21 Billion CNY 79.487%
Zhejiang Shengda Bio-Pharm Co., Ltd. 74.18 Million CNY -788.513%
Zhejiang Starry Pharmaceutical Co.,Ltd. 464.77 Million CNY -41.817%
ChengDu ShengNuo Biotec Co.,Ltd. 267.6 Million CNY -146.308%
Changchun BCHT Biotechnology Co. 1.6 Billion CNY 58.837%
Kangmei Pharmaceutical Co., Ltd. 715.07 Million CNY 7.822%
Guobang Pharma Ltd. 1.2 Billion CNY 45.474%
Yabao Pharmaceutical Group Co., Ltd 1.66 Billion CNY 60.393%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 1.65 Billion CNY 60.177%
Hubei Jumpcan Pharmaceutical Co., Ltd. 7.74 Billion CNY 91.49%
Shandong Lukang Pharmaceutical Co.,Ltd. 1.46 Billion CNY 54.877%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 1.32 Billion CNY 50.341%
Shandong Buchang Pharmaceuticals Co., Ltd. 8.7 Billion CNY 92.426%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 528.34 Million CNY -24.754%
Shanghai Haoyuan Chemexpress Co., Ltd. 759.03 Million CNY 13.16%
Zhejiang Huahai Pharmaceutical Co., Ltd. 4.83 Billion CNY 86.37%
Harbin Pharmaceutical Group Co., Ltd. 3.76 Billion CNY 82.502%
Zhejiang Medicine Co., Ltd. 2.52 Billion CNY 73.888%
HPGC Renmintongtai Pharmaceutical Corporation 986.11 Million CNY 33.158%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.59 Billion CNY 81.64%
Lionco Pharmaceutical Group Co.,Ltd. 86.95 Million CNY -658.018%
Humanwell Healthcare (Group) Co.,Ltd. 10.65 Billion CNY 93.814%
Ginwa Enterprise (Group) Inc. 431.65 Million CNY -52.702%
KPC Pharmaceuticals, Inc. 3.33 Billion CNY 80.235%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 361.03 Million CNY -82.567%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 765.77 Million CNY 13.926%
Ningbo Menovo Pharmaceutical Co., Ltd. 342.7 Million CNY -92.334%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.07 Billion CNY 68.31%
Nanjing Well Pharmaceutical Group Co.,Ltd. 312.86 Million CNY -110.675%
Henan Lingrui Pharmaceutical Co., Ltd. 2.42 Billion CNY 72.842%
Joincare Pharmaceutical Group Industry Co.,Ltd. 9.79 Billion CNY 93.271%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 5.61 Billion CNY 88.262%
Chongqing Taiji Industry(Group) Co.,Ltd 7.13 Billion CNY 90.765%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 13.54 Billion CNY 95.134%
China National Medicines Corporation Ltd. 3.85 Billion CNY 82.889%
Shenzhen Chipscreen Biosciences Co., Ltd. 433.54 Million CNY -52.034%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.84 Billion CNY 64.219%
Zhongzhu Healthcare Holding Co.,Ltd -114.92 Million CNY 673.528%
Beijing Tongrentang Co., Ltd 8.3 Billion CNY 92.062%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 735.98 Million CNY 10.442%
Jianmin Pharmaceutical Group Co.,Ltd. 1.88 Billion CNY 64.967%
Tibet Weixinkang Medicine Co., Ltd. 672.1 Million CNY 1.929%
CanSino Biologics Inc. -876.01 Million CNY 175.242%
Zhejiang Hisun Pharmaceutical Co., Ltd. 4.18 Billion CNY 84.247%
Shanghai Jiaoda Onlly Co.,Ltd 62.19 Million CNY -959.77%
Jiang Zhong Pharmaceutical Co.,Ltd 2.74 Billion CNY 76.012%
Mayinglong Pharmaceutical Group Co., LTD. 1.3 Billion CNY 49.579%
Cisen Pharmaceutical Co., Ltd. 2.54 Billion CNY 74.148%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 431.02 Million CNY -52.922%
Hunan Warrant Pharmaceutical Co.,Ltd 928.23 Million CNY 28.99%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 19.8 Billion CNY 96.672%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.1 Billion CNY 40.419%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 183.75 Million CNY -258.714%
Henan Taloph Pharmaceutical Stock Co.,Ltd 538.56 Million CNY -22.388%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.39 Billion CNY 85.0%
Shanghai Yizhong Pharmaceutical Co., Ltd. 336.2 Million CNY -96.054%
Tibet Rhodiola Pharmaceutical Holding Co. 2.94 Billion CNY 77.589%
Sichuan Huiyu Pharmaceutical Co., Ltd. 787.59 Million CNY 16.31%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.04 Billion CNY 36.864%